HIF-1α protects osteoblasts from ROS-induced apoptosis. (1st February 2022)

• Record Type: Journal Article
• Authors: Wang, Xiaohui; Wei, Lili; Li, Qiaochuan; Lai, Yongrong
• Is Part Of: Free radical research. Volume 56:Number 2(2022)
• Page Start: 143
• Page End: 153
• Publication Date: 2022-02-01
• Subjects: HIF-1α -- HIF-2α -- ROS; Free radicals (Chemistry) -- Periodicals; Antioxidants -- Periodicals; Vitamin C -- Periodicals; Vitamin E -- Periodicals; 541.224
• DOI: 10.1080/10715762.2022.2037581
• Languages: English
• ISSNs: 1071-5762

Abstract

Abstract: The regulatory mechanism of hypoxia-inducible factor-1α (HIF-1α) is complex. HIF-1α may inhibit or promote apoptosis in osteoblasts under different physiological conditions, and induce bone regeneration and repair injury in coordination with angiogenesis. The relationship between H2 O2 and HIFs is complex, and this study aimed to explore the role of HIF-1α in H2 O2 -induced apoptosis. Dimethyloxallyl glycine (DMOG) and 2-Methoxyestradiol (2ME) were used to stabilize and inhibit HIFs, respectively. Cell viability was assessed with CCK8. Apoptosis and ROS levels were detected by flow cytometry, and HIF mRNA expression was assessed by reverse transcription-polymerase chain reaction (RT-PCR). Western blot was performed to detect HIF-1α, HIF-2α, Bax, Bak, Bcl-2, Bcl-XL, caspase-9, and PCNA protein amounts. Our data suggest that both HIF-1α and HIF-2α play a protective role in oxidative stress. HIF-1α reduces H2 O2 -induced apoptosis by upregulating Bcl-2 and Bcl-XL, downregulating Bax, Bak, and caspase-9, stabilizing intracellular ROS levels, and promoting the repair of H2 O2 -induced DNA damage to reduce apoptosis.